Quick Hits: FDA Issues Warning Letters to CBD Makers

The FDA also released a revised Consumer Update outlining new safety concerns for CBD products. To date, the FDA has only approved one prescription drug containing CBD, which treats rare forms of childhood epilepsy. Since then, businesses have made far-reaching claims about their own CBD products, labelling them as cure-alls. The warning letters say that the FDA has tested these products, and they don’t do what they claim. One industry insider estimated that 90-95% of CBD companies are fraudulent because they have no testing, authorizations, or certifications.